Latest Insider Transactions at Neuro Bo Pharmaceuticals, Inc. (NRBO)
This section provides a real-time view of insider transactions for Neuro Bo Pharmaceuticals, Inc. (NRBO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NeuroBo Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NeuroBo Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2024
|
Hyung Heon Kim CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,867
-4.3%
|
$5,734
$2.55 P/Share
|
|
Sep 12
2024
|
Dong A St Co., LTD |
SELL
Open market or private sale
|
Direct |
407
-0.01%
|
$1,221
$3.75 P/Share
|
|
Aug 11
2024
|
Hyung Heon Kim CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,467
-14.68%
|
$34,401
$3.6 P/Share
|
|
Jun 23
2024
|
Dong A St Co., LTD |
BUY
Open market or private purchase
|
Direct |
2,544,530
+32.24%
|
$7,633,590
$3.13 P/Share
|
|
Jun 07
2024
|
D Gordon Strickland Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+22.35%
|
-
|
|
Jun 07
2024
|
Mark A Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+34.15%
|
-
|
|
Jun 07
2024
|
Andrew I Koven Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+22.35%
|
-
|
|
Jun 07
2024
|
Jason L Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+22.35%
|
-
|
|
Jun 07
2024
|
Michael Salsbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+22.35%
|
-
|
|
Jun 07
2024
|
James Patrick Tursi Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,051
+35.76%
|
-
|
|
Mar 01
2024
|
Marshall H Woodworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,496
+50.0%
|
-
|
|
Dec 01
2023
|
James Patrick Tursi Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,157
+34.1%
|
-
|
|
Aug 11
2023
|
Hyung Heon Kim CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
625,064
+50.0%
|
-
|
|
Jul 27
2023
|
Andrew I Koven Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.56%
|
-
|
|
Jul 27
2023
|
D Gordon Strickland Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.56%
|
-
|
|
Jul 27
2023
|
Michael Salsbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.56%
|
-
|
|
Jul 27
2023
|
Mark A Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+37.5%
|
-
|
|
Jul 27
2023
|
Jason L Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.56%
|
-
|
|
Jul 27
2023
|
Na Yeon Kim Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.28%
|
-
|
|
Jul 26
2022
|
Na Yeon Kim Director |
SELL
Other acquisition or disposition
|
Indirect |
1,445,267
-33.33%
|
-
|
|
Jul 26
2022
|
E&Investment, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,445,267
-33.33%
|
-
|
|
Dec 31
2020
|
Akash Bakshi SVP and COO |
BUY
Grant, award, or other acquisition
|
Indirect |
855,059
+49.17%
|
-
|
|
Dec 31
2020
|
Akash Bakshi SVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
29,013
+50.0%
|
-
|